Steroidlerin etkileri

Side effects of anabolic steroids with relevance in forensic medicine are mainly due to life-threatening health risks with potential fatal outcome and cases of uncertain limitations of criminal liability after steroid administration. Both problems are typically associated with long-term abuse and excessive overdose of anabolic steroids. Side effects may be due to direct genomic or nongenomic activities (myotrophic, hepatotoxic), can result from down-regulation of endogenous biosynthesis (antiandrogenic) or be indirect consequence of steroid biotransformation (estrogenic).Logically, there are no systematic clinical studies available and the number of causally determined fatalities is fairly limited. The following compilation reviews typical abundant observations in cases where nonnatural deaths (mostly liver failure and sudden cardiac death) were concurrent with steroid abuse. Moreover, frequent associations between structural characteristics and typical side effects are summarized.

1. 1. Pei, Y, Cattran, D, Greenwood, C: Predicting chronic renal
insufficiency in idiopathic membranous glomerulonephritis.
Kidney Int 1992; 42:960-966
2. Shiiki, H, Saito, T, Nishitani, Y, et al: Prognosis and risk factors for
idiopathic membranous nephropathy with nephrotic syndrome in
Japan. Kidney Int 2004; 65:1400-1407
3. Bazzi, C, Petrini, C, Rizza, V, Arrigo, G: A modern approach to
selectivity of proteinuria and tubulointerstitial damage in nephrotic
syndrome. Kidney Int 2000; 58:1732-1741
4. Schieppati, A, Mosconi, L, Perna, A, et al: Prognosis of untreated
patients with idiopathic membranous nephropathy. N Engl J Med
1993; 329:85-89
5. A controlled study of short-term prednisone treatment in adults
with membranous nephropathy. Collaborative Study of the Adult
Idiopathic Nephrotic Syndrome. N Engl J Med 1979; 301:1301-
6. Bolton, WK, Atuk, NO, Sturgill, BC, Westervelt, FB Jr:Therapy of
the idiopathic nephrotic syndrome with alternate day steroids. Am
J Med 1977; 62:60-70
7. Cattran, DC, Delmore, T, Roscoe, J, et al: A randomized controlled
trial of prednisone in patients with idiopathic membranous
nephropathy. N Engl J Med 1989; 320:210-215
8. Cameron, JS, Healy, MJ, Adu, D: The Medical Research Council
trial of short-term high-dose alternate day prednisolone in idiopathic
membranous nephropathy in adults. Q J Med 1990; 74:133-156
9. Wehrmann M, Bohle A, Bogenschütz O, Eissele R, Freislederer
A, Ohlschlegel C. Schumm G, Batz C, Gärtner HV: Long-term
prognosis of chronic idiopathic membranous glomerulonephritis.
An analysis of 334 cases with particular regard to tubulo-interstitial
changes. Clin Nephrol. 1989;31:67-76
10. Reichert LJ, Koene RA, Wetzels JF: Prognostic factors in idiopathic
membranous nephropathy. Am J Kidney Dis. 1998;31:1-11
11. Cockcroft DW, Gault MH: Prediction of creatinine clearance from
serum creatinine. Nephron 1976:16: 31–41
12. Takei T, Aoki A, Eguchi A, Shimizu A, Iwasa Y, Asamiya Y,
Matsuda N, Sugiura H, Itabashi M, Shirota S, Tsukada M, Yoshida
T, Uchida K, Tsuchiya K, Nitta K: [Effects of steroid therapy on
membranous nephropathy] Nippon Jinzo Gakkai Shi. 2008;50:597-
13. Perna A, Schieppati A, Zamora J, Giuliano GA, Braun N, Remuzzi
G: Immunosuppressive treatment for idiopathic membranous
nephropathy: a systematic review. Am J Kidney Dis. 2004;44:385-
14. Schieppati A, Ruggenenti P, Perna A, Remuzzi G:
Nonimmunosuppressive therapy of membranous nephropathy.
Semin Nephrol. 2003;23:333-339
ÖZTÜRK: İdiyopatik Membranöz Nefropatinin Başlangıç
Tedavisinde Steroidler

Steroidlerin etkileri

steroidlerin etkileri


steroidlerin etkileristeroidlerin etkileristeroidlerin etkileristeroidlerin etkileristeroidlerin etkileri